prostaglandin E2

May 24, 2022

Diabetes, cardiovascular drug targets

Targeting receptors of the inflammatory lipid signaling molecule PGE2 may offer a new way to tackle both Type 2 diabetes and cardiovascular disease, Vanderbilt researchers have discovered.

By Leigh MacMillan

gloved hand placing test tube on rack full of other test tubes

December 7, 2017

Searching out pancreatic cancer risk

Vanderbilt researchers have identified a biomarker that could be used to predict pancreatic cancer risk.